Eris Lifesciences share price
You have to be logged in to add this to Watchlist.- ₹1,385.00(-2.31%)January 23, 2026 15:29:01 PM IST
- NSE
- BSE
- Vol : 101.57 K (NSE + BSE)Last 20 day avg : 72.22 K
Eris Lifesciences is trading -2.31% lower at Rs 1,385.00 as compared to its last closing price. Eris Lifesciences has been trading in the price range of 1,417.90 & 1,373.20. Eris Lifesciences has given -5.77% in this year & -3.75% in the last 5 days. Eris Lifesciences has TTM P/E ratio 52.01 as compared to the sector P/E of 22.37.There are 10 analysts who have initiated coverage on Eris Lifesciences. There are 3 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 120.19 Crores in its last quarter.Listed peers of Eris Lifesciences include Sun Pharmaceutical Industries (-0.24%), Torrent Pharmaceuticals (-2.48%), Dr Reddy's Laboratories (1.48%).The Mutual Fund holding in Eris Lifesciences was at 18.26% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Eris Lifesciences was at 6.85% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 23, 2026, 07:37 PM UTC
- BetaLow volatility0.68Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.87The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.52Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-9.79The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,630.45 | -0.24 | 3,91,070.72 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Neutral | 3,924.15 | -2.48 | 1,32,927.95 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Neutral | 1,235.15 | 1.48 | 1,03,084.54 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Bearish | 1,314.85 | -4.13 | 1,06,175.04 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Bearish | 6,007.00 | -1.08 | 1,59,244.08 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-24 | Preferential issue of shares |
| 2025-11-12 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-07 | Interim Dividend |
- IndustryBiotechnology & Drugs
- ISININE406M01024
- BSE Code540596
- NSE CodeERIS
Eris Lifesciences is trading at 1385.00 as on Fri Jan 23 2026 09:59:01. This is -2.31% lower as compared to its previous closing price of 1417.70.
The market capitalization of Eris Lifesciences is 18898.03 Cr as on Fri Jan 23 2026 09:59:01.
The average broker rating on Eris Lifesciences is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 2 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Eris Lifesciences is 1909.55 whereas the 52 wk low is 1130.05
Eris Lifesciences can be analyzed on the following key metrics -
- TTM P/E: 52.01
- Sector P/E: 22.37
- Dividend Yield: 0.52%
- D/E ratio: 0.77
Eris Lifesciences reported a net profit of 351.84 Cr in 2025.
The Mutual Fund Shareholding was 18.26% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Eris Lifesciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.